Tonmya (Sublingual Cyclobenzaprine HCl) in Fibromyalgia and Chronic Pain: A Psychopharmacologic Perspective – Brief Commentary
Psychopharmacology Bulletin · 29.10.2026 · 56 (4) · 153-156
DOI: 10.64719/pb.21627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychopharmacology Bulletin, online erschienen am 29.10.2026. Verfasst von Mridul Sarangal. Beteiligte Einrichtung: Dr. Sarangal, is a third-year psychiatry resident, Department of Psychiatry and Behavioral Medicine at Carilion Clinic - Virginia Tech Carilion Schoo…. Hauptthemen laut MEDLINE: Amitriptyline, Chronic Pain, Fibromyalgia. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Objective
To review the psychopharmacologic profile of Tonmya (cyclobenzaprine HCl sublingual tablets), FDA-approved August 15, 2025, as the first new fibromyalgia therapy in over 15 years, and provide practical guidance for integration in cases with psychiatric comorbidity. Observations Tonmya targets sleep disruption, pain, and fatigue via receptor antagonism (5-HT2A serotonergic, α1-adrenergic, H1-histaminergic, M1-muscarinic), with sublingual delivery reducing daytime sedation. Phase 3 RESILIENT trial data showed significant pain reduction (p < 0.0001, effect size 0.38 at week 14), sleep/fatigue improvements, and favorable tolerability.
Conclusions
Psychiatrists and collaborators can use Tonmya adjunctively in fibromyalgia with mood/somatic features, emphasizing patient selection, documentation, monitoring, and multidisciplinary care to minimize risks and enhance outcomes in psychosomatic pain syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dr. Sarangal, is a third-year psychiatry resident, Department of Psychiatry and Behavioral Medicine at Carilion Clinic - Virginia Tech Carilion School of Medicine, Roanoke, Virginia.
Zitieren
APA
Sarangal, M. (2026). Tonmya (Sublingual Cyclobenzaprine HCl) in Fibromyalgia and Chronic Pain: A Psychopharmacologic Perspective – Brief Commentary. Psychopharmacology Bulletin, 56(4), 153-156. https://doi.org/10.64719/pb.21627
Vancouver
Sarangal M. Tonmya (Sublingual Cyclobenzaprine HCl) in Fibromyalgia and Chronic Pain: A Psychopharmacologic Perspective – Brief Commentary. Psychopharmacology Bulletin. 2026;56(4):153-156. doi:10.64719/pb.21627
BibTeX
@article{Sarangal2026,
author = {Sarangal, Mridul},
title = {Tonmya (Sublingual Cyclobenzaprine HCl) in Fibromyalgia and Chronic Pain: A Psychopharmacologic Perspective – Brief Commentary},
journal = {Psychopharmacology Bulletin},
year = {2026},
volume = {56},
number = {4},
pages = {153--156},
doi = {10.64719/pb.21627}
}
EUVIMED